Compare SNTI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNTI | CNVS |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8M | 60.1M |
| IPO Year | 2021 | 2016 |
| Metric | SNTI | CNVS |
|---|---|---|
| Price | $0.97 | $3.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 164.0K | ★ 436.5K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.99 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $78,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $150.00 | $30.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.13 |
| 52 Week Low | $0.80 | $1.77 |
| 52 Week High | $5.10 | $7.39 |
| Indicator | SNTI | CNVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 67.66 |
| Support Level | $0.80 | $2.47 |
| Resistance Level | $1.19 | $3.49 |
| Average True Range (ATR) | 0.07 | 0.27 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 72.05 | 75.99 |
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.